Tip Card: Ninlaro® (ixazomib)

This proteasome inhibitor is indicated for patients with myeloma who have received at least one prior therapy.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.